JPMorgan Chase & Co. Issues Pessimistic Forecast for Medtronic …

Nov 18, 2024 · Medtronic (NYSE:MDT – Free Report) had its target price lowered by JPMorgan Chase & Co. from $99.00 to $96.00 in a report released on Friday morning. JPMorgan Chase …

$99.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Medtronic …

4 weeks from now

Nov 18, 2024 · Medtronic (NYSE:MDT – Free Report) had its target price lowered by JPMorgan Chase & Co. from $99.00 to $96.00 in a report released on Friday morning. JPMorgan Chase …

etfdailynews.com

$99.00
OFF

JPMorgan Chase & Co. Cuts Medtronic (NYSE:MDT) Price Target …

4 weeks from now

Nov 19, 2024 · Medtronic (NYSE:MDT – Free Report) had its price target decreased by JPMorgan Chase & Co. from $99.00 to $96.00 in a research note released on Friday. …

defenseworld.net

$93.33
OFF

15 Analysts Assess Medtronic: What You Need To Know

4 weeks from now

Oct 8, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $93.33, along with a high estimate of $106.00 and a low …

nasdaq.com

$170.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Science ...

4 weeks from now

Dec 7, 2024 · Science Applications International (NYSE:SAIC - Free Report) had its target price decreased by JPMorgan Chase & Co. from $170.00 to $148.00 in a report issued on Friday …

marketbeat.com

$97.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Dollar …

4 weeks from now

Nov 5, 2024 · JPMorgan Chase & Co. cut their target price on Dollar General from $97.00 to $82.00 and set a "neutral" rating on the stock in a research note on Tuesday. ... JPMorgan …

marketbeat.com

$42
OFF

Medtronic Hires JPMorgan Analyst, And Investors Rate It A ‘Buy’

4 weeks from now

May 7, 2018 · For about 20 years at JPMorgan Chase & Co., Mike Weinstein covered Medtronic Plc as an analyst, raising his target price on the stock from $42 to $90. Now he’s …

bloomberg.com

3%
OFF

The Zacks Analyst Blog JPMorgan, Medtronic, Shopify And Perma …

4 weeks from now

Oct 9, 2024 · (You can read the full research report on JPMorgan Chase here >>>) Medtronic’s shares have gained +8.3% over the year-to-date period against the Zacks Medical - Products …

nasdaq.com

$118.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Global …

4 weeks from now

Nov 1, 2024 · Global Payments (NYSE:GPN – Free Report) had its target price trimmed by JPMorgan Chase & Co. from $118.00 to $115.00 in a report released on Tuesday morning, …

mayfieldrecorder.com

$8.50
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Inter & Co, …

4 weeks from now

Dec 13, 2024 · Inter & Co, Inc. (NASDAQ:INTR - Get Free Report) had its target price decreased by investment analysts at JPMorgan Chase & Co. from $8.50 to $7.20 in a research note …

marketbeat.com

$16.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Dana

4 weeks from now

Nov 11, 2024 · Dana (NYSE:DAN – Get Free Report) had its price objective reduced by investment analysts at JPMorgan Chase & Co. from $16.00 to $14.00 in a report released on …

techdows.com

$16.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Dana …

4 weeks from now

Nov 12, 2024 · Dana (NYSE:DAN – Free Report) had its target price reduced by JPMorgan Chase & Co. from $16.00 to $14.00 in a research report sent to investors on …

mayfieldrecorder.com

$510.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For Vertex ...

4 weeks from now

Nov 7, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target reduced by JPMorgan Chase & Co. from $510.00 to $503.00 in a research report issued on …

defenseworld.net

59%
OFF

Okta (NASDAQ:OKTA) Price Target Cut To $85.00 By Analysts At …

4 weeks from now

Nov 30, 2024 · JPMorgan Chase & Co.'s price objective would suggest a potential upside of 9.59% from the company's previous close. Get Okta alerts: Sign Up. Several other equities …

marketbeat.com

$125.00
OFF

JPMorgan Chase & Co. Issues Pessimistic Forecast For BioNTech …

4 weeks from now

Nov 5, 2024 · BioNTech (NASDAQ:BNTX – Free Report) had its target price cut by JPMorgan Chase & Co. from $125.00 to $124.00 in a report published on Monday morning, Benzinga …

mayfieldrecorder.com

FAQs about JPMorgan Chase & Co. Issues Pessimistic Forecast for Medtronic … Coupon?

Should you buy JPMorgan Chase (JPM) stock?

The average analyst rating for JPMorgan Chase stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP. Sources: Price targets and analyst ratings provided by Benzinga. ...

How do analysts evaluate Medtronic's stock?

Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Medtronic's stock. This comparison reveals trends in analysts' expectations over time. Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Medtronic's market standing. ...

What is a Medtronic stock rating?

Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Medtronic compared to the broader market. ...

Does Medtronic have a good return on equity?

This signifies efficient cost management and strong financial health. Return on Equity (ROE): Medtronic's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.12%, the company may encounter challenges in delivering satisfactory returns for shareholders. ...

Is Medtronic a good company?

Net Margin: Medtronic's net margin excels beyond industry benchmarks, reaching 13.16%. This signifies efficient cost management and strong financial health. Return on Equity (ROE): Medtronic's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. ...